Qilu Hospital, Shandong University
Welcome,         Profile    Billing    Logout  
 94 Trials 
119 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Yanqing
NCT05432115: Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Recruiting
4
407
RoW
Tetracyclin, Amoxicillin, Esomeprazole, Bismuth
Shandong University, Peking University Care Luzhong Hospital, Zibo Central Hospital, Zhengzhou Central Hospital, Taierzhuang District People's Hospital, Yuncheng Traditional Chinese Medicine Hospital
Helicobacter Pylori Infection
08/23
10/23
NCT05802888: Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Recruiting
4
260
RoW
Tetracycline 500mg tid, Amoxicillin, Esomeprazole, Bismuth, Tetracycline 500mg qid
Shandong University, Peking University Care Luzhong Hospital, Zibo Central Hospital, Yuncheng County Hospital of Traditional Chinese Medicine, Taierzhuang District People's Hospital, People's Hospital of Zhengzhou University
Helicobacter Pylori Infection
06/24
06/24
LUCENT-1, NCT03518086 / 2017-003229-14: An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Checkmark Full data from P3 LUCENT 1 trial for severe ulcerative colitis
Oct 2022 - Oct 2022: Full data from P3 LUCENT 1 trial for severe ulcerative colitis
Checkmark Efficacy and safety data from LUCENT-1 trial for moderately-to-severely active ulcerative colitis
Feb 2022 - Feb 2022: Efficacy and safety data from LUCENT-1 trial for moderately-to-severely active ulcerative colitis
Checkmark From LUCENT 1 trial for ulcerative colitis
More
Completed
3
1281
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828, Placebo
Eli Lilly and Company
Ulcerative Colitis
01/21
05/24
LUCENT-2, NCT03524092 / 2017-003238-96: A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Checkmark Efficacy and safety data of LUCENT-2 in patients with ulcerative colitis
May 2022 - May 2022: Efficacy and safety data of LUCENT-2 in patients with ulcerative colitis
Checkmark Safety and efficacy data from LUCENT-2 trial for ulcerative colitis
Dec 2021 - Dec 2021: Safety and efficacy data from LUCENT-2 trial for ulcerative colitis
Completed
3
1177
Europe, Canada, Japan, US, RoW
Mirikizumab SC, LY3074828, Mirikizumab IV, Placebo SC
Eli Lilly and Company
Ulcerative Colitis
11/21
12/24
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
LUCENT-3, NCT03519945 / 2017-004092-31: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Hourglass Jan 2022 - Mar 2022 : Data from LUCENT 3 trial for moderate-to-severe ulcerative colitis
Recruiting
3
1063
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Ulcerative Colitis
07/26
12/27
NCT04411589: The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System

Recruiting
N/A
300
RoW
magnifying endoscopy with optical enhancement system, white light endoscopy system
Shandong University
Early Gastric Cancer
05/21
05/22
NCT04720924: AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract

Completed
N/A
1840
RoW
Computer-aided Real-time Automatic Quality-control System
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Peking University Care Luzhong Hospital, Linyi People's Hospital, Zibo municipal hospital
Esophagogastroduodenoscopy
06/23
12/23
NCT04485715: Application of AI in Polypectomy

Recruiting
N/A
1000
RoW
AI system
Yanqing Li
Colonic Polyp
07/21
09/21
NCT04901130: Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection

Not yet recruiting
N/A
1254
RoW
Computer-aided Real-time Automatic Quality Control System (AQCS)
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Linyi People's Hospital, Zibo municipal hospital, The People's Hospital of Zhaoyuan City
Colonoscopy
01/22
01/22
NCT04954677: A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy

Completed
N/A
194
RoW
AI-box
Shandong University, Ancon Technologies Ltd, Shandong Provincial Hospital, Binzhou Medical University
Magnet Controlled Capsule Endoscopy
07/22
08/22
NCT04956679: Family-based Screening and Treatment of Helicobacter Pylori:A Real World Study

Recruiting
N/A
400
RoW
carbon 13 breath test
Shandong University
Helicobacter Pylori, Family
05/22
06/22
NCT04933643: Analysis of Influencing Factors of Gastric Preparation Quality for MCCG

Recruiting
N/A
240
RoW
Shandong University
Capsule Endoscopy
08/22
03/23
NCT05321472: Artificial Intelligence-assisted Common Bile Duct Stent Selection in Endoscopic Retrograde Cholangiopancreatography

Recruiting
N/A
600
RoW
Shandong University
Stenosis of Bile Duct, Endoscopic Retrograde Cholangiopancreatography
08/22
04/23
NCT04856423: Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer

Recruiting
N/A
6000
RoW
The us-qFIT and colonoscopy with pathological examination
Shandong University, Shanghai Tongji Hospital, Tongji University School of Medicine, Tianjin Medical University General Hospital, Binzhou Medical University, Weihai Municipal Hospital, People's Hospital of Lixia District of Jinan
Colorectal Neoplasm
04/23
06/23
NCT05870683: Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)

Recruiting
N/A
368
RoW
Tegoprazan, Amoxicillin, Esomeprazole
Yanqing Li, Linyi People's Hospital, Weifang Medical University, Zhengzhou Central Hospital, Yuncheng Traditional Chinese Medicine Hospital, The Affiliated Hospital of Qingdao University, The People's Hospital of Jimo, The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine
Helicobacter Pylori Infection
10/23
12/23
NCT05448898: The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction

Recruiting
N/A
278
RoW
Traditional Chinese Medicine CU Xiu Tang, Olfactory Training
Eye & ENT Hospital of Fudan University
Olfactory Disorder
11/23
12/23
NCT05447221: Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System

Recruiting
N/A
150
RoW
The diagnosis of Artificial Intelligence and pathologists
Shandong University
Gastric Intestinal Metaplasia, Artificial Intelligence, Pathology, Gastric Cancer
12/23
12/23
NCT05997433: Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori(SHARE2302)

Recruiting
N/A
254
RoW
7days bismuth quadruple, Amoxicillin, Tetracycline, Bismuth, Tegoprazan, 14 days bismuth quadruple
Shandong University, Zibo Maternal and Child Health Hospital, Zaozhuang Municipal Hospital, Binzhou Maternal and Child Health Hospital, Jinxiang County People's Hospital, Linyi Yizhou Hospital, Yantai Penglai Traditional Chinese Medicine Hospital, The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine
Helicobacter Pylori Infection
08/24
08/24
NCT05458388: Different Endoscopic Gastric Cancer Risk Assessments

Recruiting
N/A
3500
RoW
Kimura-Takemoto classification, EGGIM
Yanqing Li
Gastric Cancer Screening
12/24
07/25
NCT05916014: AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis

Recruiting
N/A
1500
RoW
Diagnostic Test: The diagnosis of Artificial Intelligence and endosopists
Shandong University, Linyi County People's Hospital,Dezhou,China
Atrophic Gastritis, Artificial Intelligence, Endoscopy
12/24
12/24
NCT04563416: Application of Artificial Intelligence for Early Diagnosis of Gastric Cancer During Optical Enhancement Magnifying Endoscopy

Recruiting
N/A
80
RoW
Shandong University
Artificial Intelligence, Optical Enhancement Endoscopy, Magnifying Endoscopy
11/20
12/20
NCT05459610: Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence

Recruiting
N/A
600
RoW
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, Endoscopy
12/23
12/23
NCT05462743: Artificial Intelligence-assisted Confocal Laser Endomicroscopy Identification of Intestinal Metaplasia Severity

Recruiting
N/A
1000
RoW
Shandong University
Intestinal Metaplasia, Artificial Intelligence, Confocal Laser Endomicroscopy
12/23
12/23
NCT05464108: Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia

Completed
N/A
1080
RoW
The diagnosis of Artificial Intelligence and endosopists
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, Endoscopy
12/23
12/23
NCT05459428: Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.

Recruiting
N/A
250
RoW
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Confocal Laser Endomicroscopy
06/24
06/24
NCT05380791: Effect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After ARS in Patients With GERD

Recruiting
N/A
70
RoW
Follow-up visits, Questionnaire to assess symptoms and quality of life etc.
Shandong University
Esophageal Motility Disorders
04/26
06/26
Hou, Ming
NCT03998982: Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Recruiting
4
30
RoW
Glycyrrhetinic Acid, Dexamethasone
Shandong University
Immune Thrombocytopenia
06/21
06/21
NCT05236621: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Active, not recruiting
3
85
RoW
Pomalidomide, Dexamethasone
Qilu Pharmaceutical Co., Ltd.
Multiple Myeloma, Recurrent or Refractory
06/22
12/23
postMONARCH, NCT05169567 / 2021-002301-10: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Active, not recruiting
3
368
Europe, US, RoW
Abemaciclib, Fulvestrant, Placebo
Eli Lilly and Company, Eli Lilly and Company
Breast Neoplasm, Neoplasm Metastasis
02/24
02/26
LUNA3, NCT04562766 / 2020-002063-60: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Active, not recruiting
3
232
Europe, Canada, Japan, US, RoW
Rilzabrutinib, PRN1008, Placebo, PRN1008 Placebo
Principia Biopharma, a Sanofi Company, Principia Biopharma, Inc.
Immune Thrombocytopenia
01/25
08/26
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Active, not recruiting
3
150
RoW
SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone)
Antengene Corporation
Relapsed or Refractory Multiple Myeloma
12/25
12/25
BELIEVE-01, NCT05234684: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma

Recruiting
3
150
RoW
Orelabrutinib + R-CHOP, ICP-022+ R-CHOP, Placebo + R-CHOP
Beijing InnoCare Pharma Tech Co., Ltd.
Diffuse Large B Cell Lymphoma (DLBCL)
07/24
12/25
OASIS, NCT05101187: Olorofim Aspergillus Infection Study

Recruiting
3
225
Europe, Canada, Japan, US, RoW
Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)
F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi
Invasive Aspergillosis
09/25
11/26
NCT06900920: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

Not yet recruiting
3
199
RoW
TQB3473 Tablets, TQB3473 Placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Primary Immune Thrombocytopenia
03/27
12/27
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Recruiting
3
195
RoW
Orelabrutinib, Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Chronic Primary Immune Thrombocytopenia (ITP)
12/25
04/26
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Recruiting
3
552
RoW
Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)
TJ Biopharma Co., Ltd.
Myelodysplastic Syndromes(MDS)
03/27
03/27
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
8000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
NCT03692754: Atorvastatin in Management of Newly Diagnosed ITP

Not yet recruiting
2/3
30
RoW
Atorvastatin 20mg, atorvastatin calcium, Atorvastatin 10mg, Dexamethasone
Shandong University
Immune Thrombocytopenia, Purpura, Thrombocytopenic
12/21
12/23
NCT05232149: A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Recruiting
2a/2b
30
RoW
Orelabrutinib( lower dose), Orelabrutinib( higher dose)
Beijing InnoCare Pharma Tech Co., Ltd.
Primary Immune Thrombocytopenia
12/23
12/24
NCT05023915: A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Recruiting
2
106
RoW
dexamethasone, diammonium glycyrrhizinate enteric-coated capsule
Shandong University
Immune Thrombocytopenia
08/21
07/22
NCT04233346: The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Active, not recruiting
2
90
RoW
Ponatinib, Iclusig, AP24534
Otsuka Beijing Research Institute
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
07/22
12/25
NCT05020288: A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Not yet recruiting
2
40
NA
Orelabrutinib, ICP-022
Shandong University
Immune Thrombocytopenia, Bruton's Tyrosine Kinase
12/23
06/24
LUMMICAR STUDY 1, NCT03975907: Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma

Active, not recruiting
1/2
121
RoW
CAR-BCMA T Cells
CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University
Multiple Myeloma
12/24
12/25
NCT06853444: A Phase 1/2 Study of ESG206 in Patients with Primary Immune Thrombocytopenia

Not yet recruiting
1/2
84
RoW
ESG206, ESG206-2
Shanghai Escugen Biotechnology Co., Ltd
Immune Thrombocytopenia (ITP)
03/26
04/27
NCT04949009: Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Recruiting
N/A
400
RoW
Avatrombopag, Doptelet
Shandong University
Primary Immune Thrombocytopenia
10/21
03/22
Yang, Yun Sh
NCT04390737: Evaluate the Safety and Clinical Activity of HH2853

Recruiting
1/2
254
US, RoW
HH2853 Tablets
Haihe Biopharma Co., Ltd.
FL Lymphoma, Epithelioid Sarcoma, Peripheral T Cell Lymphoma, Advanced Solid Tumor
12/25
12/25
NCT05687318: A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment

Completed
N/A
337
RoW
DeFrame
Peking Union Medical College Hospital, the Second Affiliated Hospital of South China University, The Loudi Central Hospital
Artificial Intelligence, Enteroscope, Intestinal Polyposis, Adenomatous
04/23
08/23
Chen, Yuguo
NCT04728516: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Not yet recruiting
4
2600
RoW
Vonoprazan-based dual eradication therapy for two weeks, amoxicillin, Pantoprazole
Qilu Hospital of Shandong University
Acute Coronary Syndrome, Helicobacter Pylori Infection
01/23
06/23
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

Recruiting
4
2260
RoW
Recombinant staphylokinase, Placebo
The First Affiliated Hospital with Nanjing Medical University
ST Elevation Myocardial Infarction
12/26
12/27
NCT05437900: INSIGHTFUL-FFR Clinical Trial

Recruiting
4
2500
Europe, RoW
Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care
CoreAalst BV, Insight Lifetech Co., Ltd.
Coronary Artery Disease, Acute Coronary Syndrome
06/26
06/30
BEST, NCT04305106: Bevacizumab in Patients With Severe Covid-19

Recruiting
3
588
RoW
Bevacizumab, Recombinant anti-VEGF humanized monoclonal antibody injection, Placebo, Inactive excipient, Standard care
Qilu Hospital of Shandong University, China-Japan Friendship Hospital, Renmin Hospital of Wuhan University, Second Affiliated Hospital of Xi'an Jiaotong University, Zhejing Provincial People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Anqing Municipal Hospital, The First Affiliated Hospital of Wannan Medical College, The Fourth Affiliated Hospital Zhejing University School of Medicine, Shandong Provincial Hospital, Linyi People's Hospital, Jining Medical University, Shandong Jining No.1 People's Hospital, Weifang Second People's Hospital, Weifang Medical University, Yantai Yuhuangding Hospital, Weihai Municipal Hospital, Rizhao People's Hospital, Qingdao Municipal Hospital, Qilu Hospital of Shandong University (Qingdao), Weifang People's Hospital, Weifang Hospital of Traditional Chinese Medicine, Zibo Central Hospital, Zibo municipal hospital
COVID-19 Pneumonia
11/23
12/23
NCT05922436: a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency

Not yet recruiting
3
378
NA
QLG2071, Clevidipine Butyrate Injectable Emulsion, Cleviprex®
Qilu Pharmaceutical (Hainan) Co., Ltd.
Hypertensive Emergency
05/24
05/24
NCT06669884: Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department

Recruiting
N/A
8000
RoW
Cardiodynamicsgram (CDG)
Qilu Hospital of Shandong University
Chest Pain, Acute Coronary Syndrome
09/24
10/24
NCT05392712: Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Recruiting
N/A
430
RoW
Magnetometer
Qilu Hospital of Shandong University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Weifang People's Hospital, Linyi People's Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Central hospital Affiliated to Shandong First Medical University, Weihai Central Hospital, Heze Municipal Hospital
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
08/24
12/24
NCT06197724: MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Recruiting
N/A
2224
RoW
Magnetocardiography
Qilu Hospital of Shandong University, Linyi People's Hospital, Weifang People's Hospital, Jining First People's Hospital, Weihai Central Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, First People's Hospital of Hangzhou, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Non ST Segment Elevation Acute Coronary Syndrome
12/24
01/25
NCT06198777: Determination of MCG Reference Intervals in Healthy Individuals

Recruiting
N/A
2396
RoW
Magnetometer
Qilu Hospital of Shandong University, Linyi People's Hospital, Weifang People's Hospital, Jining First People's Hospital, Weihai Central Hospital, The First Affiliated Hospital with Nanjing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Chongqing Emergency Medical Center, Heze Municipal Hospital, Central hospital Affiliated to Shandong First Medical University
MCG Reference Intervals Determination for Healthy Adults, Health, Subjective
10/24
12/24
MCG-SPECT, NCT06255769: Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard

Recruiting
N/A
228
RoW
Magnetocardiography, Single photon emission computed tomography (SPECT)
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center
Chest Pain, Stenosis, Myocardial Ischemia
10/24
12/24
NCT06327425: MCG for Localization of Tachyarrhythmia's Origin

Recruiting
N/A
1000
RoW
Magnetocardiography
Qilu Hospital of Shandong University
Tachyarrhythmia, Atrial Flutter, Paroxysmal Supraventricular Tachycardia, Atrial Tachycardia, Atrial Fibrillation, Premature Ventricular Contraction
12/24
02/25
NCT06315998: Diagnosis of Structural Heart Disease Using MCG

Recruiting
N/A
2914
RoW
Magnetocardiography
Qilu Hospital of Shandong University
Structural Heart Abnormality
04/25
09/25
NCT06316011: MCG for Risk Stratifications of Patients With Chest Pain

Recruiting
N/A
3620
RoW
Magnetocardiography
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, First People's Hospital of Hangzhou, Guangdong Provincial Hospital of Traditional Chinese Medicine, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Acute Coronary Syndrome
10/24
12/24
NCT05896826: Magnetocardiography in the Accurate Identification of Myocardial Infarction

Recruiting
N/A
500
RoW
Magnetometer
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, First People's Hospital of Hangzhou
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
10/24
12/24
MNM-ECPR, NCT06711016: Multimodal Neurological Monitoring Strategy After Receiving ECPR

Not yet recruiting
N/A
654
RoW
fluid resuscitation, vasoactive drug dose,hemoglobin transfusion,sedative analgesic muscle relaxant drugs, antiepileptic drugs, etc, Device
Qilu Hospital of Shandong University, China-Japan Friendship Hospital, The First Affiliated Hospital of Zhengzhou University, Second Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Zhengzhou University
Cardiac Arrest
05/28
07/28
NCT05682573: Study on Immune Status of Patients With COVID-19

Recruiting
N/A
500
RoW
hospitalized patient
Qilu Hospital of Shandong University
COVID-19, Immunity, Life Quality
11/23
12/23
Zuo, Xiuli
NCT04101708: A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients

Not yet recruiting
4
100
RoW
Lansoprazole, Amoxicillin, Lansoprazole, Amoxicillin,Clarithromycin and Bismuth subcitrate
Shandong University
Helicobacter Pylori
09/21
09/22
NCT05129176: Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

Recruiting
4
106
RoW
Levofloxacin, Metronidazole
Shandong University
Helicobacter Pylori Infection
07/22
11/22
NCT05431075: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Completed
4
406
RoW
Amoxicillin, Tetracycline tid, Tetracycline qid, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Esomeprazole 20mg
Shandong University, Peking University Care Luzhong Hospital, Yuncheng Traditional Chinese Medicine Hospital, Taierzhuang District People's Hospital, Zhengzhou Central Hospital, Zibo Central Hospital
Helicobacter Pylori Infection
02/24
02/24
NCT04122287: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

Recruiting
4
250
RoW
Levofloxacin, tinidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT05135182: Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin

Recruiting
4
170
RoW
Furazolidone, Metronidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT04264663: Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

Recruiting
4
250
RoW
Furazolidone, Tinidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT05049902: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Completed
4
1300
RoW
Amoxicillin, Clarithromycin, Tetracycline, Metronidazole, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Vonoprazan fumarate
Shandong University, Maternity and Child Care Health Center of Dezhou, Heze Municipal 3rd people's hospital, Peking University Care Luzhong Hospital, The People's Hospital of Jimo.Qingdao
Helicobacter Pylori Infection
05/23
06/23
NCT04901117: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Not yet recruiting
4
1300
RoW
Amoxicillin, Clarithromycin, Tetracycline, Metronidazole, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Vonoprazan fumarate
Shandong University, The Affiliated Hospital of Qingdao University, The People's Hospital of Guangrao, Weihai Municipal Hospital, Shandong Provincial Third Hospital, Taian City Central Hospital, Jining No.2 People's Hospital, Maternity and Child Care Health Center of Dezhou, Zoucheng People's Hospital, Heze Municipal 3rd people's hospital, Yuncheng Chengxin Hospital, PKUcare luzhong hospital, Qihe County City Hospital, Weifang People's Hospital, Qilu Hospital of Shandong University, Shandong Electric Power Central Hospital
Helicobacter Pylori Infection
06/23
08/23
NCT05438550: 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

Not yet recruiting
4
258
RoW
14-day high-dose Tegoprazan Dual Therapy (HDDT), Tegoprazan (Rosin Pharmaceutical Group Co. LTD.) 50mg bid, Amoxicillin (Amoxicillin, United Laboratories Co. LTD) 750mg qid
Shandong University
Helicobacter Pylori Infection
12/23
12/23
NCT05486104: Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Recruiting
2
108
RoW
Hemay005 tablets, Hemay005 45 mg BID group, Hemay005 placebo tablets, Hemay005 placebo BID group
Ganzhou Hemay Pharmaceutical Co., Ltd
Moderate to Severe Ulcerative Colitis
06/24
09/24
NCT04901130: Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection

Not yet recruiting
N/A
1254
RoW
Computer-aided Real-time Automatic Quality Control System (AQCS)
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Linyi People's Hospital, Zibo municipal hospital, The People's Hospital of Zhaoyuan City
Colonoscopy
01/22
01/22
NCT04970277: Efficacy of Drinking Water During Capsule Endoscopy

Recruiting
N/A
120
RoW
drinking water group, control group
Shandong University
Capsule Endoscopy
04/22
05/22
NCT05126121: Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection

Not yet recruiting
N/A
60
RoW
three kinds of antibiotics including amoxicillin,tetracycline, furazolidone, levofloxacin,clarithromycin,levofloxacin,tinidazole,metronidazol, antibiotics
Xiuli Zuo
Helicobacter Pylori Infection
06/22
12/22
NCT04984382: Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists

Recruiting
N/A
2000
RoW
Standardized training on Helicobacter pylori eradication treatment
Shandong University
Helicobacter Pylori Infection
09/22
09/22
NCT05065138: Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists

Completed
N/A
1025
RoW
Standardized training on Helicobacter pylori eradication treatment
Shandong University
Helicobacter Pylori Infection
12/23
12/23
NCT03748563: Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

Completed
N/A
607
RoW
ds-MCE and EGD
Changhai Hospital, Ruijin Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai East Hospital of Tongji University, Yangpu District Central Hospital Affiliated to Tongji University, Zhujiang Hospital, Qilu Hospital of Shandong University, The Third Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, Wuhan Union Hospital, China, The Fifth Affiliated Hospital of Zunyi Medical College, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shanghai Pudong New Area Gongli Hospital
Liver Cirrhosis, Portal Hypertension, Esophageal Varices, Gastric Varix
01/23
03/23
NCT05173493: The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

Completed
N/A
670
RoW
Amoxicillin,Furazolidone, Amoxicillin,Levofloxacin, Tetracycline,Furazolidone
Shandong University, Taian City Central Hospital, Dezhou People's Hospital, Weifang Medical University, The Affiliated Hospital of Qingdao University, Shengli Oilfield Hospital
Helicobacter Pylori Infection
02/23
02/23
NCT05576506: Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy

Completed
N/A
86
RoW
Shandong University
Colorectal Neoplasms, Colorectal Polyp, Colorectal Adenoma, Colorectal SSA
12/22
12/22
NCT04872491: A Study of Vedolizumab in Adults in Real-World Practice

Completed
N/A
500
RoW
Takeda
Colitis, Ulcerative, Crohn Disease
07/24
07/24
NCT05369572: Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence

Not yet recruiting
N/A
1500
RoW
Shandong University
Artificial Intelligence, Tongue, Bile Reflux
06/24
06/25
NCT05368636: Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence

Not yet recruiting
N/A
4000
RoW
Shandong University
Artificial Intelligence, Tongue, Gastric Cancer
06/24
06/25
NCT06895772: Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD

Active, not recruiting
N/A
50
RoW
Shandong University
Crohn's Disease (CD)
10/25
12/25
NCT06877559: Balloon-Assisted Enteroscopic Treatment for Phytobezoar

Active, not recruiting
N/A
20
RoW
balloon-assisted enteroscopic treatment for phytobezoar
Shandong University
Phytobezoar; Intestine
06/25
07/25
NCT06731023: Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

Not yet recruiting
N/A
30
RoW
Bismuth, Vonoprazan, Amoxicillin, Rifabutin, Metronidazole, Other antibiotics
Xiuli Zuo
HELICOBACTER PYLORI INFECTIONS
12/26
12/26
NCT04811599: Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases Depending on Tongue Images

Enrolling by invitation
N/A
2000
RoW
Shandong University
Gastrointestinal Disease
06/22
06/22
Peng, Jun
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Not yet recruiting
3
500
RoW
TQH2722 injection, Placebo of TQH2722 injection
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Atopic Dermatitis
10/25
06/26
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Recruiting
3
182
RoW
Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Graft-versus-host Disease
10/29
12/30
NCT06450067: Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Recruiting
N/A
200
RoW
Juventas Cell Therapy Ltd.
B-cell Acute Lymphoblastic Leukemia
06/26
06/29
Xu, Lidong
NCT05431075: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Completed
4
406
RoW
Amoxicillin, Tetracycline tid, Tetracycline qid, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Esomeprazole 20mg
Shandong University, Peking University Care Luzhong Hospital, Yuncheng Traditional Chinese Medicine Hospital, Taierzhuang District People's Hospital, Zhengzhou Central Hospital, Zibo Central Hospital
Helicobacter Pylori Infection
02/24
02/24
Hou, Yu
NCT04917679: Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Completed
2
102
RoW
Eltrombopag plus diacerein, Eltrombopag
Qilu Hospital of Shandong University
Thrombocytopenia
12/21
06/22
NCT06579287: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Recruiting
2
144
US, RoW
SHJ002, Atropine
Sunhawk Vision Biotech, Inc.
Myopia, Progressive
04/26
04/26
Liu, Yanping
NCT05034549: Noninvasive Ventilation for Chronic Heart Failure

Recruiting
N/A
150
RoW
Noninvasive ventilation
Qilu Hospital of Shandong University
Chronic Stable Heart Failure
02/23
08/23
Wang, Limei
NCT04464135: Effect of Water Exchange Plus Acetic Acid Staining on the Detection of Flat Polyps During Colonoscopy

Recruiting
N/A
300
RoW
acetic acid staining, Water exchange colonoscopy
Fourth Military Medical University
Adenoma Colon
04/21
05/21
NCT06756139: Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia

Recruiting
N/A
88
RoW
cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets
Air Force Military Medical University, China, Xi'an 986 Hospital, Shaanxi Second People's Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Tang-Du Hospital, Hainan People's Hospital
Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug
11/25
11/25
Wang, Donghai
NCT06479343: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Recruiting
N/A
170
RoW
Liquid Embolic System (Tonbridge), Onyx Liquid Embolic System (Medtronic)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Arteriovenous Malformations
10/25
10/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Yanqing
NCT05432115: Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Recruiting
4
407
RoW
Tetracyclin, Amoxicillin, Esomeprazole, Bismuth
Shandong University, Peking University Care Luzhong Hospital, Zibo Central Hospital, Zhengzhou Central Hospital, Taierzhuang District People's Hospital, Yuncheng Traditional Chinese Medicine Hospital
Helicobacter Pylori Infection
08/23
10/23
NCT05802888: Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Recruiting
4
260
RoW
Tetracycline 500mg tid, Amoxicillin, Esomeprazole, Bismuth, Tetracycline 500mg qid
Shandong University, Peking University Care Luzhong Hospital, Zibo Central Hospital, Yuncheng County Hospital of Traditional Chinese Medicine, Taierzhuang District People's Hospital, People's Hospital of Zhengzhou University
Helicobacter Pylori Infection
06/24
06/24
LUCENT-1, NCT03518086 / 2017-003229-14: An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Checkmark Full data from P3 LUCENT 1 trial for severe ulcerative colitis
Oct 2022 - Oct 2022: Full data from P3 LUCENT 1 trial for severe ulcerative colitis
Checkmark Efficacy and safety data from LUCENT-1 trial for moderately-to-severely active ulcerative colitis
Feb 2022 - Feb 2022: Efficacy and safety data from LUCENT-1 trial for moderately-to-severely active ulcerative colitis
Checkmark From LUCENT 1 trial for ulcerative colitis
More
Completed
3
1281
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828, Placebo
Eli Lilly and Company
Ulcerative Colitis
01/21
05/24
LUCENT-2, NCT03524092 / 2017-003238-96: A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Checkmark Efficacy and safety data of LUCENT-2 in patients with ulcerative colitis
May 2022 - May 2022: Efficacy and safety data of LUCENT-2 in patients with ulcerative colitis
Checkmark Safety and efficacy data from LUCENT-2 trial for ulcerative colitis
Dec 2021 - Dec 2021: Safety and efficacy data from LUCENT-2 trial for ulcerative colitis
Completed
3
1177
Europe, Canada, Japan, US, RoW
Mirikizumab SC, LY3074828, Mirikizumab IV, Placebo SC
Eli Lilly and Company
Ulcerative Colitis
11/21
12/24
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
LUCENT-3, NCT03519945 / 2017-004092-31: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Hourglass Jan 2022 - Mar 2022 : Data from LUCENT 3 trial for moderate-to-severe ulcerative colitis
Recruiting
3
1063
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Ulcerative Colitis
07/26
12/27
NCT04411589: The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System

Recruiting
N/A
300
RoW
magnifying endoscopy with optical enhancement system, white light endoscopy system
Shandong University
Early Gastric Cancer
05/21
05/22
NCT04720924: AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract

Completed
N/A
1840
RoW
Computer-aided Real-time Automatic Quality-control System
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Peking University Care Luzhong Hospital, Linyi People's Hospital, Zibo municipal hospital
Esophagogastroduodenoscopy
06/23
12/23
NCT04485715: Application of AI in Polypectomy

Recruiting
N/A
1000
RoW
AI system
Yanqing Li
Colonic Polyp
07/21
09/21
NCT04901130: Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection

Not yet recruiting
N/A
1254
RoW
Computer-aided Real-time Automatic Quality Control System (AQCS)
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Linyi People's Hospital, Zibo municipal hospital, The People's Hospital of Zhaoyuan City
Colonoscopy
01/22
01/22
NCT04954677: A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy

Completed
N/A
194
RoW
AI-box
Shandong University, Ancon Technologies Ltd, Shandong Provincial Hospital, Binzhou Medical University
Magnet Controlled Capsule Endoscopy
07/22
08/22
NCT04956679: Family-based Screening and Treatment of Helicobacter Pylori:A Real World Study

Recruiting
N/A
400
RoW
carbon 13 breath test
Shandong University
Helicobacter Pylori, Family
05/22
06/22
NCT04933643: Analysis of Influencing Factors of Gastric Preparation Quality for MCCG

Recruiting
N/A
240
RoW
Shandong University
Capsule Endoscopy
08/22
03/23
NCT05321472: Artificial Intelligence-assisted Common Bile Duct Stent Selection in Endoscopic Retrograde Cholangiopancreatography

Recruiting
N/A
600
RoW
Shandong University
Stenosis of Bile Duct, Endoscopic Retrograde Cholangiopancreatography
08/22
04/23
NCT04856423: Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer

Recruiting
N/A
6000
RoW
The us-qFIT and colonoscopy with pathological examination
Shandong University, Shanghai Tongji Hospital, Tongji University School of Medicine, Tianjin Medical University General Hospital, Binzhou Medical University, Weihai Municipal Hospital, People's Hospital of Lixia District of Jinan
Colorectal Neoplasm
04/23
06/23
NCT05870683: Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)

Recruiting
N/A
368
RoW
Tegoprazan, Amoxicillin, Esomeprazole
Yanqing Li, Linyi People's Hospital, Weifang Medical University, Zhengzhou Central Hospital, Yuncheng Traditional Chinese Medicine Hospital, The Affiliated Hospital of Qingdao University, The People's Hospital of Jimo, The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine
Helicobacter Pylori Infection
10/23
12/23
NCT05448898: The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction

Recruiting
N/A
278
RoW
Traditional Chinese Medicine CU Xiu Tang, Olfactory Training
Eye & ENT Hospital of Fudan University
Olfactory Disorder
11/23
12/23
NCT05447221: Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System

Recruiting
N/A
150
RoW
The diagnosis of Artificial Intelligence and pathologists
Shandong University
Gastric Intestinal Metaplasia, Artificial Intelligence, Pathology, Gastric Cancer
12/23
12/23
NCT05997433: Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori(SHARE2302)

Recruiting
N/A
254
RoW
7days bismuth quadruple, Amoxicillin, Tetracycline, Bismuth, Tegoprazan, 14 days bismuth quadruple
Shandong University, Zibo Maternal and Child Health Hospital, Zaozhuang Municipal Hospital, Binzhou Maternal and Child Health Hospital, Jinxiang County People's Hospital, Linyi Yizhou Hospital, Yantai Penglai Traditional Chinese Medicine Hospital, The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine
Helicobacter Pylori Infection
08/24
08/24
NCT05458388: Different Endoscopic Gastric Cancer Risk Assessments

Recruiting
N/A
3500
RoW
Kimura-Takemoto classification, EGGIM
Yanqing Li
Gastric Cancer Screening
12/24
07/25
NCT05916014: AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis

Recruiting
N/A
1500
RoW
Diagnostic Test: The diagnosis of Artificial Intelligence and endosopists
Shandong University, Linyi County People's Hospital,Dezhou,China
Atrophic Gastritis, Artificial Intelligence, Endoscopy
12/24
12/24
NCT04563416: Application of Artificial Intelligence for Early Diagnosis of Gastric Cancer During Optical Enhancement Magnifying Endoscopy

Recruiting
N/A
80
RoW
Shandong University
Artificial Intelligence, Optical Enhancement Endoscopy, Magnifying Endoscopy
11/20
12/20
NCT05459610: Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence

Recruiting
N/A
600
RoW
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, Endoscopy
12/23
12/23
NCT05462743: Artificial Intelligence-assisted Confocal Laser Endomicroscopy Identification of Intestinal Metaplasia Severity

Recruiting
N/A
1000
RoW
Shandong University
Intestinal Metaplasia, Artificial Intelligence, Confocal Laser Endomicroscopy
12/23
12/23
NCT05464108: Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia

Completed
N/A
1080
RoW
The diagnosis of Artificial Intelligence and endosopists
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, Endoscopy
12/23
12/23
NCT05459428: Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.

Recruiting
N/A
250
RoW
Shandong University
Intestinal Metaplasia of Gastric Mucosa, Confocal Laser Endomicroscopy
06/24
06/24
NCT05380791: Effect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After ARS in Patients With GERD

Recruiting
N/A
70
RoW
Follow-up visits, Questionnaire to assess symptoms and quality of life etc.
Shandong University
Esophageal Motility Disorders
04/26
06/26
Hou, Ming
NCT03998982: Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Recruiting
4
30
RoW
Glycyrrhetinic Acid, Dexamethasone
Shandong University
Immune Thrombocytopenia
06/21
06/21
NCT05236621: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Active, not recruiting
3
85
RoW
Pomalidomide, Dexamethasone
Qilu Pharmaceutical Co., Ltd.
Multiple Myeloma, Recurrent or Refractory
06/22
12/23
postMONARCH, NCT05169567 / 2021-002301-10: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Active, not recruiting
3
368
Europe, US, RoW
Abemaciclib, Fulvestrant, Placebo
Eli Lilly and Company, Eli Lilly and Company
Breast Neoplasm, Neoplasm Metastasis
02/24
02/26
LUNA3, NCT04562766 / 2020-002063-60: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Active, not recruiting
3
232
Europe, Canada, Japan, US, RoW
Rilzabrutinib, PRN1008, Placebo, PRN1008 Placebo
Principia Biopharma, a Sanofi Company, Principia Biopharma, Inc.
Immune Thrombocytopenia
01/25
08/26
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Active, not recruiting
3
150
RoW
SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone)
Antengene Corporation
Relapsed or Refractory Multiple Myeloma
12/25
12/25
BELIEVE-01, NCT05234684: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma

Recruiting
3
150
RoW
Orelabrutinib + R-CHOP, ICP-022+ R-CHOP, Placebo + R-CHOP
Beijing InnoCare Pharma Tech Co., Ltd.
Diffuse Large B Cell Lymphoma (DLBCL)
07/24
12/25
OASIS, NCT05101187: Olorofim Aspergillus Infection Study

Recruiting
3
225
Europe, Canada, Japan, US, RoW
Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)
F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi
Invasive Aspergillosis
09/25
11/26
NCT06900920: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

Not yet recruiting
3
199
RoW
TQB3473 Tablets, TQB3473 Placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Primary Immune Thrombocytopenia
03/27
12/27
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Recruiting
3
195
RoW
Orelabrutinib, Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Chronic Primary Immune Thrombocytopenia (ITP)
12/25
04/26
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Recruiting
3
552
RoW
Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)
TJ Biopharma Co., Ltd.
Myelodysplastic Syndromes(MDS)
03/27
03/27
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
8000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
NCT03692754: Atorvastatin in Management of Newly Diagnosed ITP

Not yet recruiting
2/3
30
RoW
Atorvastatin 20mg, atorvastatin calcium, Atorvastatin 10mg, Dexamethasone
Shandong University
Immune Thrombocytopenia, Purpura, Thrombocytopenic
12/21
12/23
NCT05232149: A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Recruiting
2a/2b
30
RoW
Orelabrutinib( lower dose), Orelabrutinib( higher dose)
Beijing InnoCare Pharma Tech Co., Ltd.
Primary Immune Thrombocytopenia
12/23
12/24
NCT05023915: A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Recruiting
2
106
RoW
dexamethasone, diammonium glycyrrhizinate enteric-coated capsule
Shandong University
Immune Thrombocytopenia
08/21
07/22
NCT04233346: The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Active, not recruiting
2
90
RoW
Ponatinib, Iclusig, AP24534
Otsuka Beijing Research Institute
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
07/22
12/25
NCT05020288: A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Not yet recruiting
2
40
NA
Orelabrutinib, ICP-022
Shandong University
Immune Thrombocytopenia, Bruton's Tyrosine Kinase
12/23
06/24
LUMMICAR STUDY 1, NCT03975907: Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma

Active, not recruiting
1/2
121
RoW
CAR-BCMA T Cells
CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University
Multiple Myeloma
12/24
12/25
NCT06853444: A Phase 1/2 Study of ESG206 in Patients with Primary Immune Thrombocytopenia

Not yet recruiting
1/2
84
RoW
ESG206, ESG206-2
Shanghai Escugen Biotechnology Co., Ltd
Immune Thrombocytopenia (ITP)
03/26
04/27
NCT04949009: Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Recruiting
N/A
400
RoW
Avatrombopag, Doptelet
Shandong University
Primary Immune Thrombocytopenia
10/21
03/22
Yang, Yun Sh
NCT04390737: Evaluate the Safety and Clinical Activity of HH2853

Recruiting
1/2
254
US, RoW
HH2853 Tablets
Haihe Biopharma Co., Ltd.
FL Lymphoma, Epithelioid Sarcoma, Peripheral T Cell Lymphoma, Advanced Solid Tumor
12/25
12/25
NCT05687318: A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment

Completed
N/A
337
RoW
DeFrame
Peking Union Medical College Hospital, the Second Affiliated Hospital of South China University, The Loudi Central Hospital
Artificial Intelligence, Enteroscope, Intestinal Polyposis, Adenomatous
04/23
08/23
Chen, Yuguo
NCT04728516: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Not yet recruiting
4
2600
RoW
Vonoprazan-based dual eradication therapy for two weeks, amoxicillin, Pantoprazole
Qilu Hospital of Shandong University
Acute Coronary Syndrome, Helicobacter Pylori Infection
01/23
06/23
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

Recruiting
4
2260
RoW
Recombinant staphylokinase, Placebo
The First Affiliated Hospital with Nanjing Medical University
ST Elevation Myocardial Infarction
12/26
12/27
NCT05437900: INSIGHTFUL-FFR Clinical Trial

Recruiting
4
2500
Europe, RoW
Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care
CoreAalst BV, Insight Lifetech Co., Ltd.
Coronary Artery Disease, Acute Coronary Syndrome
06/26
06/30
BEST, NCT04305106: Bevacizumab in Patients With Severe Covid-19

Recruiting
3
588
RoW
Bevacizumab, Recombinant anti-VEGF humanized monoclonal antibody injection, Placebo, Inactive excipient, Standard care
Qilu Hospital of Shandong University, China-Japan Friendship Hospital, Renmin Hospital of Wuhan University, Second Affiliated Hospital of Xi'an Jiaotong University, Zhejing Provincial People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Anqing Municipal Hospital, The First Affiliated Hospital of Wannan Medical College, The Fourth Affiliated Hospital Zhejing University School of Medicine, Shandong Provincial Hospital, Linyi People's Hospital, Jining Medical University, Shandong Jining No.1 People's Hospital, Weifang Second People's Hospital, Weifang Medical University, Yantai Yuhuangding Hospital, Weihai Municipal Hospital, Rizhao People's Hospital, Qingdao Municipal Hospital, Qilu Hospital of Shandong University (Qingdao), Weifang People's Hospital, Weifang Hospital of Traditional Chinese Medicine, Zibo Central Hospital, Zibo municipal hospital
COVID-19 Pneumonia
11/23
12/23
NCT05922436: a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency

Not yet recruiting
3
378
NA
QLG2071, Clevidipine Butyrate Injectable Emulsion, Cleviprex®
Qilu Pharmaceutical (Hainan) Co., Ltd.
Hypertensive Emergency
05/24
05/24
NCT06669884: Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department

Recruiting
N/A
8000
RoW
Cardiodynamicsgram (CDG)
Qilu Hospital of Shandong University
Chest Pain, Acute Coronary Syndrome
09/24
10/24
NCT05392712: Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Recruiting
N/A
430
RoW
Magnetometer
Qilu Hospital of Shandong University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Weifang People's Hospital, Linyi People's Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Central hospital Affiliated to Shandong First Medical University, Weihai Central Hospital, Heze Municipal Hospital
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
08/24
12/24
NCT06197724: MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Recruiting
N/A
2224
RoW
Magnetocardiography
Qilu Hospital of Shandong University, Linyi People's Hospital, Weifang People's Hospital, Jining First People's Hospital, Weihai Central Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, First People's Hospital of Hangzhou, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Non ST Segment Elevation Acute Coronary Syndrome
12/24
01/25
NCT06198777: Determination of MCG Reference Intervals in Healthy Individuals

Recruiting
N/A
2396
RoW
Magnetometer
Qilu Hospital of Shandong University, Linyi People's Hospital, Weifang People's Hospital, Jining First People's Hospital, Weihai Central Hospital, The First Affiliated Hospital with Nanjing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Chongqing Emergency Medical Center, Heze Municipal Hospital, Central hospital Affiliated to Shandong First Medical University
MCG Reference Intervals Determination for Healthy Adults, Health, Subjective
10/24
12/24
MCG-SPECT, NCT06255769: Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard

Recruiting
N/A
228
RoW
Magnetocardiography, Single photon emission computed tomography (SPECT)
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center
Chest Pain, Stenosis, Myocardial Ischemia
10/24
12/24
NCT06327425: MCG for Localization of Tachyarrhythmia's Origin

Recruiting
N/A
1000
RoW
Magnetocardiography
Qilu Hospital of Shandong University
Tachyarrhythmia, Atrial Flutter, Paroxysmal Supraventricular Tachycardia, Atrial Tachycardia, Atrial Fibrillation, Premature Ventricular Contraction
12/24
02/25
NCT06315998: Diagnosis of Structural Heart Disease Using MCG

Recruiting
N/A
2914
RoW
Magnetocardiography
Qilu Hospital of Shandong University
Structural Heart Abnormality
04/25
09/25
NCT06316011: MCG for Risk Stratifications of Patients With Chest Pain

Recruiting
N/A
3620
RoW
Magnetocardiography
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, First People's Hospital of Hangzhou, Guangdong Provincial Hospital of Traditional Chinese Medicine, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Acute Coronary Syndrome
10/24
12/24
NCT05896826: Magnetocardiography in the Accurate Identification of Myocardial Infarction

Recruiting
N/A
500
RoW
Magnetometer
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, First People's Hospital of Hangzhou
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
10/24
12/24
MNM-ECPR, NCT06711016: Multimodal Neurological Monitoring Strategy After Receiving ECPR

Not yet recruiting
N/A
654
RoW
fluid resuscitation, vasoactive drug dose,hemoglobin transfusion,sedative analgesic muscle relaxant drugs, antiepileptic drugs, etc, Device
Qilu Hospital of Shandong University, China-Japan Friendship Hospital, The First Affiliated Hospital of Zhengzhou University, Second Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Zhengzhou University
Cardiac Arrest
05/28
07/28
NCT05682573: Study on Immune Status of Patients With COVID-19

Recruiting
N/A
500
RoW
hospitalized patient
Qilu Hospital of Shandong University
COVID-19, Immunity, Life Quality
11/23
12/23
Zuo, Xiuli
NCT04101708: A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients

Not yet recruiting
4
100
RoW
Lansoprazole, Amoxicillin, Lansoprazole, Amoxicillin,Clarithromycin and Bismuth subcitrate
Shandong University
Helicobacter Pylori
09/21
09/22
NCT05129176: Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

Recruiting
4
106
RoW
Levofloxacin, Metronidazole
Shandong University
Helicobacter Pylori Infection
07/22
11/22
NCT05431075: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Completed
4
406
RoW
Amoxicillin, Tetracycline tid, Tetracycline qid, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Esomeprazole 20mg
Shandong University, Peking University Care Luzhong Hospital, Yuncheng Traditional Chinese Medicine Hospital, Taierzhuang District People's Hospital, Zhengzhou Central Hospital, Zibo Central Hospital
Helicobacter Pylori Infection
02/24
02/24
NCT04122287: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

Recruiting
4
250
RoW
Levofloxacin, tinidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT05135182: Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin

Recruiting
4
170
RoW
Furazolidone, Metronidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT04264663: Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

Recruiting
4
250
RoW
Furazolidone, Tinidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
NCT05049902: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Completed
4
1300
RoW
Amoxicillin, Clarithromycin, Tetracycline, Metronidazole, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Vonoprazan fumarate
Shandong University, Maternity and Child Care Health Center of Dezhou, Heze Municipal 3rd people's hospital, Peking University Care Luzhong Hospital, The People's Hospital of Jimo.Qingdao
Helicobacter Pylori Infection
05/23
06/23
NCT04901117: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Not yet recruiting
4
1300
RoW
Amoxicillin, Clarithromycin, Tetracycline, Metronidazole, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Vonoprazan fumarate
Shandong University, The Affiliated Hospital of Qingdao University, The People's Hospital of Guangrao, Weihai Municipal Hospital, Shandong Provincial Third Hospital, Taian City Central Hospital, Jining No.2 People's Hospital, Maternity and Child Care Health Center of Dezhou, Zoucheng People's Hospital, Heze Municipal 3rd people's hospital, Yuncheng Chengxin Hospital, PKUcare luzhong hospital, Qihe County City Hospital, Weifang People's Hospital, Qilu Hospital of Shandong University, Shandong Electric Power Central Hospital
Helicobacter Pylori Infection
06/23
08/23
NCT05438550: 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

Not yet recruiting
4
258
RoW
14-day high-dose Tegoprazan Dual Therapy (HDDT), Tegoprazan (Rosin Pharmaceutical Group Co. LTD.) 50mg bid, Amoxicillin (Amoxicillin, United Laboratories Co. LTD) 750mg qid
Shandong University
Helicobacter Pylori Infection
12/23
12/23
NCT05486104: Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Recruiting
2
108
RoW
Hemay005 tablets, Hemay005 45 mg BID group, Hemay005 placebo tablets, Hemay005 placebo BID group
Ganzhou Hemay Pharmaceutical Co., Ltd
Moderate to Severe Ulcerative Colitis
06/24
09/24
NCT04901130: Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection

Not yet recruiting
N/A
1254
RoW
Computer-aided Real-time Automatic Quality Control System (AQCS)
Shandong University, Binzhou Medical University, Central Hospital of Shengli Oilfield, Linyi People's Hospital, Zibo municipal hospital, The People's Hospital of Zhaoyuan City
Colonoscopy
01/22
01/22
NCT04970277: Efficacy of Drinking Water During Capsule Endoscopy

Recruiting
N/A
120
RoW
drinking water group, control group
Shandong University
Capsule Endoscopy
04/22
05/22
NCT05126121: Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection

Not yet recruiting
N/A
60
RoW
three kinds of antibiotics including amoxicillin,tetracycline, furazolidone, levofloxacin,clarithromycin,levofloxacin,tinidazole,metronidazol, antibiotics
Xiuli Zuo
Helicobacter Pylori Infection
06/22
12/22
NCT04984382: Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists

Recruiting
N/A
2000
RoW
Standardized training on Helicobacter pylori eradication treatment
Shandong University
Helicobacter Pylori Infection
09/22
09/22
NCT05065138: Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists

Completed
N/A
1025
RoW
Standardized training on Helicobacter pylori eradication treatment
Shandong University
Helicobacter Pylori Infection
12/23
12/23
NCT03748563: Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

Completed
N/A
607
RoW
ds-MCE and EGD
Changhai Hospital, Ruijin Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai East Hospital of Tongji University, Yangpu District Central Hospital Affiliated to Tongji University, Zhujiang Hospital, Qilu Hospital of Shandong University, The Third Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, Wuhan Union Hospital, China, The Fifth Affiliated Hospital of Zunyi Medical College, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shanghai Pudong New Area Gongli Hospital
Liver Cirrhosis, Portal Hypertension, Esophageal Varices, Gastric Varix
01/23
03/23
NCT05173493: The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

Completed
N/A
670
RoW
Amoxicillin,Furazolidone, Amoxicillin,Levofloxacin, Tetracycline,Furazolidone
Shandong University, Taian City Central Hospital, Dezhou People's Hospital, Weifang Medical University, The Affiliated Hospital of Qingdao University, Shengli Oilfield Hospital
Helicobacter Pylori Infection
02/23
02/23
NCT05576506: Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy

Completed
N/A
86
RoW
Shandong University
Colorectal Neoplasms, Colorectal Polyp, Colorectal Adenoma, Colorectal SSA
12/22
12/22
NCT04872491: A Study of Vedolizumab in Adults in Real-World Practice

Completed
N/A
500
RoW
Takeda
Colitis, Ulcerative, Crohn Disease
07/24
07/24
NCT05369572: Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence

Not yet recruiting
N/A
1500
RoW
Shandong University
Artificial Intelligence, Tongue, Bile Reflux
06/24
06/25
NCT05368636: Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence

Not yet recruiting
N/A
4000
RoW
Shandong University
Artificial Intelligence, Tongue, Gastric Cancer
06/24
06/25
NCT06895772: Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD

Active, not recruiting
N/A
50
RoW
Shandong University
Crohn's Disease (CD)
10/25
12/25
NCT06877559: Balloon-Assisted Enteroscopic Treatment for Phytobezoar

Active, not recruiting
N/A
20
RoW
balloon-assisted enteroscopic treatment for phytobezoar
Shandong University
Phytobezoar; Intestine
06/25
07/25
NCT06731023: Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

Not yet recruiting
N/A
30
RoW
Bismuth, Vonoprazan, Amoxicillin, Rifabutin, Metronidazole, Other antibiotics
Xiuli Zuo
HELICOBACTER PYLORI INFECTIONS
12/26
12/26
NCT04811599: Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases Depending on Tongue Images

Enrolling by invitation
N/A
2000
RoW
Shandong University
Gastrointestinal Disease
06/22
06/22
Peng, Jun
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Not yet recruiting
3
500
RoW
TQH2722 injection, Placebo of TQH2722 injection
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Atopic Dermatitis
10/25
06/26
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Recruiting
3
182
RoW
Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Graft-versus-host Disease
10/29
12/30
NCT06450067: Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Recruiting
N/A
200
RoW
Juventas Cell Therapy Ltd.
B-cell Acute Lymphoblastic Leukemia
06/26
06/29
Xu, Lidong
NCT05431075: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Completed
4
406
RoW
Amoxicillin, Tetracycline tid, Tetracycline qid, Bismuth Potassium Citrate, Colloidal Bismuth Pectin, Esomeprazole 20mg
Shandong University, Peking University Care Luzhong Hospital, Yuncheng Traditional Chinese Medicine Hospital, Taierzhuang District People's Hospital, Zhengzhou Central Hospital, Zibo Central Hospital
Helicobacter Pylori Infection
02/24
02/24
Hou, Yu
NCT04917679: Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Completed
2
102
RoW
Eltrombopag plus diacerein, Eltrombopag
Qilu Hospital of Shandong University
Thrombocytopenia
12/21
06/22
NCT06579287: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Recruiting
2
144
US, RoW
SHJ002, Atropine
Sunhawk Vision Biotech, Inc.
Myopia, Progressive
04/26
04/26
Liu, Yanping
NCT05034549: Noninvasive Ventilation for Chronic Heart Failure

Recruiting
N/A
150
RoW
Noninvasive ventilation
Qilu Hospital of Shandong University
Chronic Stable Heart Failure
02/23
08/23
Wang, Limei
NCT04464135: Effect of Water Exchange Plus Acetic Acid Staining on the Detection of Flat Polyps During Colonoscopy

Recruiting
N/A
300
RoW
acetic acid staining, Water exchange colonoscopy
Fourth Military Medical University
Adenoma Colon
04/21
05/21
NCT06756139: Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia

Recruiting
N/A
88
RoW
cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets
Air Force Military Medical University, China, Xi'an 986 Hospital, Shaanxi Second People's Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Tang-Du Hospital, Hainan People's Hospital
Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug
11/25
11/25
Wang, Donghai
NCT06479343: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Recruiting
N/A
170
RoW
Liquid Embolic System (Tonbridge), Onyx Liquid Embolic System (Medtronic)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Arteriovenous Malformations
10/25
10/26
 

Download Options